TickerFacts.

Dianthus Therapeutics, Inc. (DNTH): Revenue

Annual figures by period end, from SEC filings.

$2.04M
Year ended 2025-12-31
$6.24M2016-12-31: $02017-12-31: $02018-12-31: $02019-12-31: $02023-12-31: $2.83M2024-12-31: $6.24M2025-12-31: $2.04M$2.04M
2016-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$2.04M-67.3%2026-03-09, From 2025-01-01
2024-12-31$6.24M+120.6%2026-03-09, From 2024-01-01
2023-12-31$2.83Mn/a2025-03-11, From 2023-01-01
No annual figure between 2019-12-31 and 2023-12-31.
2019-12-31$0n/a2020-03-03, From 2019-01-01
2018-12-31$0n/a2020-03-03, From 2018-01-01
2017-12-31$0n/a2020-03-03, From 2017-01-01
2016-12-31$0n/a2019-03-19, From 2016-01-01

Revenue at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Dianthus Therapeutics, Inc. (DNTH)2025-12-31$2.04M-67.3%
Korsana Biosciences, Inc. (KRSA)2025-12-31$2.07M+3.7%
Lipocine Inc. (LPCN)2025-12-31$1.98M-82.3%
Bio Essence Corp (BIOE)2025-12-31$1.90M+485.8%
GeoVax Labs, Inc. (GOVX)2025-12-31$2.49M-37.1%
Rani Therapeutics Holdings, Inc. (RANI)2025-12-31$1.63M+58.9%
Cartesian Therapeutics, Inc. (RNAC)2025-12-31$2.80M-92.8%
Upstream Bio, Inc. (UPB)2025-12-31$2.85M+20.4%
NRX Pharmaceuticals, Inc. (NRXP)2025-12-31$1.45Mn/a

Compare DNTH, KRSA, LPCN, BIOE side by side · Screen every company in Pharmaceutical Preparations ↗